NFYA_HUMAN
ID NFYA_HUMAN Reviewed; 347 AA.
AC P23511; Q8IXU0;
DT 01-NOV-1991, integrated into UniProtKB/Swiss-Prot.
DT 01-MAY-1992, sequence version 2.
DT 03-AUG-2022, entry version 199.
DE RecName: Full=Nuclear transcription factor Y subunit alpha;
DE AltName: Full=CAAT box DNA-binding protein subunit A;
DE AltName: Full=Nuclear transcription factor Y subunit A;
DE Short=NF-YA;
GN Name=NFYA;
OS Homo sapiens (Human).
OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC Homo.
OX NCBI_TaxID=9606;
RN [1]
RP NUCLEOTIDE SEQUENCE [MRNA].
RX PubMed=1549471; DOI=10.1093/nar/20.5.1087;
RA Li X.-Y., Mantovani R., Hooft van Huijsduijnen R., Andre I., Benoist C.,
RA Mathis D.;
RT "Evolutionary variation of the CCAAT-binding transcription factor NF-Y.";
RL Nucleic Acids Res. 20:1087-1091(1992).
RN [2]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX PubMed=14574404; DOI=10.1038/nature02055;
RA Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R.,
RA Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D.,
RA Andrews T.D., Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J.,
RA Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H.,
RA Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J.,
RA Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E.,
RA Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J.,
RA French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J.,
RA Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C.,
RA Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A.,
RA Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R.,
RA Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M.,
RA Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K.,
RA Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R.,
RA Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A.,
RA Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L.,
RA Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I.,
RA Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y.,
RA Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E.,
RA Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A.,
RA Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W.,
RA Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M.,
RA West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J.,
RA Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M.,
RA Bentley D.R., Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Dunham I.,
RA Rogers J., Beck S.;
RT "The DNA sequence and analysis of human chromosome 6.";
RL Nature 425:805-811(2003).
RN [3]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM SHORT).
RC TISSUE=Testis;
RX PubMed=15489334; DOI=10.1101/gr.2596504;
RG The MGC Project Team;
RT "The status, quality, and expansion of the NIH full-length cDNA project:
RT the Mammalian Gene Collection (MGC).";
RL Genome Res. 14:2121-2127(2004).
RN [4]
RP NUCLEOTIDE SEQUENCE [MRNA] OF 91-347.
RX PubMed=2000400; DOI=10.1073/pnas.88.5.1968;
RA Becker D.M., Fikes J.D., Guarente L.;
RT "A cDNA encoding a human CCAAT-binding protein cloned by functional
RT complementation in yeast.";
RL Proc. Natl. Acad. Sci. U.S.A. 88:1968-1972(1991).
RN [5]
RP INTERACTION WITH ZHX1.
RX PubMed=10441475; DOI=10.1006/bbrc.1999.1087;
RA Yamada K., Printz R.L., Osawa H., Granner D.K.;
RT "Human ZHX1: cloning, chromosomal location, and interaction with
RT transcription factor NF-Y.";
RL Biochem. Biophys. Res. Commun. 261:614-621(1999).
RN [6]
RP INTERACTION WITH ZHX1.
RX PubMed=10571058; DOI=10.1016/s0014-5793(99)01311-3;
RA Yamada K., Osawa H., Granner D.K.;
RT "Identification of proteins that interact with NF-YA.";
RL FEBS Lett. 460:41-45(1999).
RN [7]
RP INTERACTION WITH ZFX3.
RC TISSUE=Testis;
RX PubMed=12659632; DOI=10.1042/bj20021866;
RA Yamada K., Kawata H., Shou Z., Hirano S., Mizutani T., Yazawa T.,
RA Sekiguchi T., Yoshino M., Kajitani T., Miyamoto K.;
RT "Analysis of zinc-fingers and homeoboxes (ZHX)-1-interacting proteins:
RT molecular cloning and characterization of a member of the ZHX family,
RT ZHX3.";
RL Biochem. J. 373:167-178(2003).
RN [8]
RP FUNCTION, AND INTERACTION WITH ZHX2.
RC TISSUE=Testis;
RX PubMed=12741956; DOI=10.1042/bj20030171;
RA Kawata H., Yamada K., Shou Z., Mizutani T., Yazawa T., Yoshino M.,
RA Sekiguchi T., Kajitani T., Miyamoto K.;
RT "Zinc-fingers and homeoboxes (ZHX) 2, a novel member of the ZHX family,
RT functions as a transcriptional repressor.";
RL Biochem. J. 373:747-757(2003).
RN [9]
RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-326, AND IDENTIFICATION BY
RP MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC TISSUE=Cervix carcinoma;
RX PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA Elledge S.J., Gygi S.P.;
RT "A quantitative atlas of mitotic phosphorylation.";
RL Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN [10]
RP INTERACTION WITH SP1.
RX PubMed=19302979; DOI=10.1016/j.bbrc.2009.03.075;
RA Lim K., Chang H.I.;
RT "O-GlcNAcylation of Sp1 interrupts Sp1 interaction with NF-Y.";
RL Biochem. Biophys. Res. Commun. 382:593-597(2009).
RN [11]
RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-326, AND IDENTIFICATION BY
RP MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC TISSUE=Cervix carcinoma, and Erythroleukemia;
RX PubMed=23186163; DOI=10.1021/pr300630k;
RA Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA Mohammed S.;
RT "Toward a comprehensive characterization of a human cancer cell
RT phosphoproteome.";
RL J. Proteome Res. 12:260-271(2013).
RN [12]
RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC TISSUE=Liver;
RX PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA Ye M., Zou H.;
RT "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT phosphoproteome.";
RL J. Proteomics 96:253-262(2014).
RN [13]
RP X-RAY CRYSTALLOGRAPHY (3.08 ANGSTROMS) OF 262-332 IN COMPLEX WITH NYFB;
RP NYFC AND PROMOTER DNA, AND SUBUNIT.
RX PubMed=23332751; DOI=10.1016/j.cell.2012.11.047;
RA Nardini M., Gnesutta N., Donati G., Gatta R., Forni C., Fossati A.,
RA Vonrhein C., Moras D., Romier C., Bolognesi M., Mantovani R.;
RT "Sequence-specific transcription factor NF-Y displays histone-like DNA
RT binding and H2B-like ubiquitination.";
RL Cell 152:132-143(2013).
CC -!- FUNCTION: Component of the sequence-specific heterotrimeric
CC transcription factor (NF-Y) which specifically recognizes a 5'-CCAAT-3'
CC box motif found in the promoters of its target genes. NF-Y can function
CC as both an activator and a repressor, depending on its interacting
CC cofactors. NF-YA positively regulates the transcription of the core
CC clock component ARNTL/BMAL1. {ECO:0000269|PubMed:12741956}.
CC -!- SUBUNIT: Heterotrimeric transcription factor composed of three
CC components, NF-YA, NF-YB and NF-YC. NF-YB and NF-YC must interact and
CC dimerize for NF-YA association and DNA binding. Interacts with SP1; the
CC interaction is inhibited by glycosylation of SP1. Interacts with ZHX1.
CC Interacts (via N-terminus) with ZHX2 (via homeobox domain). Interacts
CC with ZFX3. {ECO:0000269|PubMed:10441475, ECO:0000269|PubMed:10571058,
CC ECO:0000269|PubMed:12659632, ECO:0000269|PubMed:12741956,
CC ECO:0000269|PubMed:19302979, ECO:0000269|PubMed:23332751}.
CC -!- INTERACTION:
CC P23511; Q92624: APPBP2; NbExp=3; IntAct=EBI-389739, EBI-743771;
CC P23511; P68400: CSNK2A1; NbExp=4; IntAct=EBI-389739, EBI-347804;
CC P23511; P52655: GTF2A1; NbExp=3; IntAct=EBI-389739, EBI-389518;
CC P23511; Q9Y383: LUC7L2; NbExp=4; IntAct=EBI-389739, EBI-352851;
CC P23511; P25208: NFYB; NbExp=8; IntAct=EBI-389739, EBI-389728;
CC P23511; Q13952: NFYC; NbExp=6; IntAct=EBI-389739, EBI-389755;
CC P23511; Q7Z3K3: POGZ; NbExp=3; IntAct=EBI-389739, EBI-1389308;
CC P23511; Q07955: SRSF1; NbExp=5; IntAct=EBI-389739, EBI-398920;
CC P23511; P04637: TP53; NbExp=11; IntAct=EBI-389739, EBI-366083;
CC P23511-2; P54253: ATXN1; NbExp=3; IntAct=EBI-11061759, EBI-930964;
CC P23511-2; Q8N9N5-2: BANP; NbExp=3; IntAct=EBI-11061759, EBI-11524452;
CC P23511-2; P68400: CSNK2A1; NbExp=3; IntAct=EBI-11061759, EBI-347804;
CC P23511-2; Q92997: DVL3; NbExp=3; IntAct=EBI-11061759, EBI-739789;
CC P23511-2; P52655: GTF2A1; NbExp=3; IntAct=EBI-11061759, EBI-389518;
CC P23511-2; Q9Y383: LUC7L2; NbExp=3; IntAct=EBI-11061759, EBI-352851;
CC P23511-2; P25208: NFYB; NbExp=6; IntAct=EBI-11061759, EBI-389728;
CC P23511-2; Q13952-2: NFYC; NbExp=4; IntAct=EBI-11061759, EBI-11956831;
CC P23511-2; Q7Z3K3: POGZ; NbExp=3; IntAct=EBI-11061759, EBI-1389308;
CC P23511-2; P14859-6: POU2F1; NbExp=5; IntAct=EBI-11061759, EBI-11526590;
CC P23511-2; Q2TAL8: QRICH1; NbExp=3; IntAct=EBI-11061759, EBI-2798044;
CC P23511-2; Q9Y4C2-2: TCAF1; NbExp=3; IntAct=EBI-11061759, EBI-11974855;
CC P23511-2; Q9BZL1: UBL5; NbExp=3; IntAct=EBI-11061759, EBI-607755;
CC P23511-2; Q14119: VEZF1; NbExp=3; IntAct=EBI-11061759, EBI-11980193;
CC P23511-2; Q96K80: ZC3H10; NbExp=3; IntAct=EBI-11061759, EBI-742550;
CC -!- SUBCELLULAR LOCATION: Nucleus.
CC -!- ALTERNATIVE PRODUCTS:
CC Event=Alternative splicing; Named isoforms=2;
CC Name=Long;
CC IsoId=P23511-1; Sequence=Displayed;
CC Name=Short;
CC IsoId=P23511-2; Sequence=VSP_000849;
CC -!- SIMILARITY: Belongs to the NFYA/HAP2 subunit family.
CC {ECO:0000255|PROSITE-ProRule:PRU00966}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; X59711; CAA42231.1; -; mRNA.
DR EMBL; AL031778; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR EMBL; BC039244; AAH39244.1; -; mRNA.
DR EMBL; M59079; AAA35950.1; -; mRNA.
DR CCDS; CCDS4849.1; -. [P23511-1]
DR CCDS; CCDS4850.1; -. [P23511-2]
DR PIR; S22816; A39123.
DR RefSeq; NP_002496.1; NM_002505.4. [P23511-1]
DR RefSeq; NP_068351.1; NM_021705.3. [P23511-2]
DR PDB; 4AWL; X-ray; 3.08 A; A=262-332.
DR PDB; 6QMP; X-ray; 2.00 A; A=267-295.
DR PDB; 6QMQ; X-ray; 2.50 A; A=267-285.
DR PDB; 6QMS; X-ray; 1.80 A; A=267-285.
DR PDBsum; 4AWL; -.
DR PDBsum; 6QMP; -.
DR PDBsum; 6QMQ; -.
DR PDBsum; 6QMS; -.
DR AlphaFoldDB; P23511; -.
DR SASBDB; P23511; -.
DR SMR; P23511; -.
DR BioGRID; 110866; 75.
DR ComplexPortal; CPX-1956; CCAAT-binding factor complex.
DR CORUM; P23511; -.
DR IntAct; P23511; 39.
DR MINT; P23511; -.
DR STRING; 9606.ENSP00000345702; -.
DR GlyGen; P23511; 4 sites, 2 O-linked glycans (4 sites).
DR iPTMnet; P23511; -.
DR PhosphoSitePlus; P23511; -.
DR BioMuta; NFYA; -.
DR DMDM; 115844; -.
DR EPD; P23511; -.
DR jPOST; P23511; -.
DR MassIVE; P23511; -.
DR MaxQB; P23511; -.
DR PaxDb; P23511; -.
DR PeptideAtlas; P23511; -.
DR PRIDE; P23511; -.
DR ProteomicsDB; 54123; -. [P23511-1]
DR ProteomicsDB; 54124; -. [P23511-2]
DR Antibodypedia; 3982; 233 antibodies from 35 providers.
DR DNASU; 4800; -.
DR Ensembl; ENST00000341376.11; ENSP00000345702.6; ENSG00000001167.15. [P23511-1]
DR Ensembl; ENST00000353205.5; ENSP00000229418.6; ENSG00000001167.15. [P23511-2]
DR GeneID; 4800; -.
DR KEGG; hsa:4800; -.
DR MANE-Select; ENST00000341376.11; ENSP00000345702.6; NM_002505.5; NP_002496.1.
DR UCSC; uc003opo.4; human. [P23511-1]
DR CTD; 4800; -.
DR DisGeNET; 4800; -.
DR GeneCards; NFYA; -.
DR HGNC; HGNC:7804; NFYA.
DR HPA; ENSG00000001167; Low tissue specificity.
DR MIM; 189903; gene.
DR neXtProt; NX_P23511; -.
DR OpenTargets; ENSG00000001167; -.
DR PharmGKB; PA31609; -.
DR VEuPathDB; HostDB:ENSG00000001167; -.
DR eggNOG; KOG1561; Eukaryota.
DR GeneTree; ENSGT00390000015714; -.
DR HOGENOM; CLU_071609_1_0_1; -.
DR InParanoid; P23511; -.
DR OMA; GNMMNSG; -.
DR OrthoDB; 1269806at2759; -.
DR PhylomeDB; P23511; -.
DR TreeFam; TF323257; -.
DR PathwayCommons; P23511; -.
DR Reactome; R-HSA-1989781; PPARA activates gene expression.
DR Reactome; R-HSA-2426168; Activation of gene expression by SREBF (SREBP).
DR Reactome; R-HSA-380994; ATF4 activates genes in response to endoplasmic reticulum stress.
DR Reactome; R-HSA-381183; ATF6 (ATF6-alpha) activates chaperone genes.
DR Reactome; R-HSA-9614657; FOXO-mediated transcription of cell death genes.
DR SignaLink; P23511; -.
DR SIGNOR; P23511; -.
DR BioGRID-ORCS; 4800; 182 hits in 1103 CRISPR screens.
DR ChiTaRS; NFYA; human.
DR GeneWiki; NFYA; -.
DR GenomeRNAi; 4800; -.
DR Pharos; P23511; Tbio.
DR PRO; PR:P23511; -.
DR Proteomes; UP000005640; Chromosome 6.
DR RNAct; P23511; protein.
DR Bgee; ENSG00000001167; Expressed in cortical plate and 184 other tissues.
DR ExpressionAtlas; P23511; baseline and differential.
DR Genevisible; P23511; HS.
DR GO; GO:0016602; C:CCAAT-binding factor complex; IDA:UniProtKB.
DR GO; GO:0000785; C:chromatin; ISA:NTNU_SB.
DR GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR GO; GO:0032993; C:protein-DNA complex; IDA:ParkinsonsUK-UCL.
DR GO; GO:0090575; C:RNA polymerase II transcription regulator complex; IDA:NTNU_SB.
DR GO; GO:0003677; F:DNA binding; IDA:UniProtKB.
DR GO; GO:0003700; F:DNA-binding transcription factor activity; TAS:ProtInc.
DR GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; ISA:NTNU_SB.
DR GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; ISS:UniProtKB.
DR GO; GO:0080182; P:histone H3-K4 trimethylation; IDA:ComplexPortal.
DR GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:ComplexPortal.
DR GO; GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:UniProtKB.
DR GO; GO:0035065; P:regulation of histone acetylation; IDA:ComplexPortal.
DR GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR GO; GO:0006355; P:regulation of transcription, DNA-templated; IDA:UniProtKB.
DR GO; GO:0048511; P:rhythmic process; IEA:UniProtKB-KW.
DR GO; GO:0006366; P:transcription by RNA polymerase II; TAS:ProtInc.
DR InterPro; IPR018362; CCAAT-binding_factor_CS.
DR InterPro; IPR001289; NFYA.
DR PANTHER; PTHR12632; PTHR12632; 1.
DR Pfam; PF02045; CBFB_NFYA; 1.
DR PRINTS; PR00616; CCAATSUBUNTB.
DR SMART; SM00521; CBF; 1.
DR PROSITE; PS00686; NFYA_HAP2_1; 1.
DR PROSITE; PS51152; NFYA_HAP2_2; 1.
PE 1: Evidence at protein level;
KW 3D-structure; Activator; Alternative splicing; Biological rhythms;
KW DNA-binding; Nucleus; Phosphoprotein; Reference proteome; Transcription;
KW Transcription regulation.
FT CHAIN 1..347
FT /note="Nuclear transcription factor Y subunit alpha"
FT /id="PRO_0000198768"
FT DNA_BIND 296..321
FT /note="NFYA/HAP2-type"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00966"
FT REGION 299..347
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT MOTIF 266..289
FT /note="Subunit association domain (SAD)"
FT COMPBIAS 312..332
FT /note="Basic and acidic residues"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT MOD_RES 326
FT /note="Phosphoserine"
FT /evidence="ECO:0007744|PubMed:18669648,
FT ECO:0007744|PubMed:23186163"
FT VAR_SEQ 26..54
FT /note="Missing (in isoform Short)"
FT /evidence="ECO:0000303|PubMed:15489334"
FT /id="VSP_000849"
FT CONFLICT 273
FT /note="H -> N (in Ref. 3; AAH39244)"
FT /evidence="ECO:0000305"
FT STRAND 264..267
FT /evidence="ECO:0007829|PDB:4AWL"
FT TURN 269..271
FT /evidence="ECO:0007829|PDB:6QMS"
FT HELIX 275..278
FT /evidence="ECO:0007829|PDB:6QMS"
FT HELIX 301..309
FT /evidence="ECO:0007829|PDB:4AWL"
FT HELIX 314..316
FT /evidence="ECO:0007829|PDB:4AWL"
SQ SEQUENCE 347 AA; 36877 MW; D00BE17041EB1A9E CRC64;
MEQYTANSNS STEQIVVQAG QIQQQQQGGV TAVQLQTEAQ VASASGQQVQ TLQVVQGQPL
MVQVSGGQLI TSTGQPIMVQ AVPGGQGQTI MQVPVSGTQG LQQIQLVPPG QIQIQGGQAV
QVQGQQGQTQ QIIIQQPQTA VTAGQTQTQQ QIAVQGQQVA QTAEGQTIVY QPVNADGTIL
QQVTVPVSGM ITIPAASLAG AQIVQTGANT NTTSSGQGTV TVTLPVAGNV VNSGGMVMMV
PGAGSVPAIQ RIPLPGAEML EEEPLYVNAK QYHRILKRRQ ARAKLEAEGK IPKERRKYLH
ESRHRHAMAR KRGEGGRFFS PKEKDSPHMQ DPNQADEEAM TQIIRVS
